Novo Nordisk Makes $2.1 Billion Rare-Disease Bet After Losing Ground in Obesity Race
- Posted on October 15, 2025
- By Yahoo News
- 4 Views
Novo Nordisk Makes $2.1 Billion Rare-Disease Bet After Losing Ground in Obesity Race
The Ozempic maker doubles down on bold acquisitions, striking a high-stakes deal with Omeros to rebuild momentum.
